Cat Scratch Disease Presenting as Fever of Unknown Origin Is a Unique Clinical Syndrome.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
31 12 2020
Historique:
received: 17 08 2019
accepted: 21 11 2019
pubmed: 24 11 2019
medline: 29 4 2021
entrez: 24 11 2019
Statut: ppublish

Résumé

Fever of unknown origin (FUO) is a rare manifestation of cat scratch disease (CSD). Data regarding CSD-associated FUO (CSD-FUO), particularly in adults, are limited. We aimed to study disease manifestations and long-term clinical outcome. A national CSD surveillance study has been conducted in Israel since 1991. Data are obtained using questionnaires, review of medical records, and telephone interviews. FUO was defined as fever of ≥14 days without an identifiable cause. CSD-FUO patients were identified in the 2004-2017 CSD national registry. Follow-up included outpatient clinic visits and telephone/e-mail surveys. The study included 66 CSD-FUO patients. Median age was 35.5 years (range, 3-88). Median fever duration was 4 weeks (range, 2-9). Relapsing fever pattern was reported in 52% of patients, weight loss in 57%, and night sweats in 48%. Involvement of ≥1 organs occurred in 59% of patients; hepatosplenic space-occupying lesions (35%), abdominal/mediastinal lymphadenopathy (20%), ocular disease (18%), and multifocal osteomyelitis (6%) were the most common. Malignancy, particularly lymphoma, was the initial radiological interpretation in 21% of patients; 32% underwent invasive diagnostic procedures. Of the 59 patients available for follow-up (median duration, 31 weeks; range, 4-445), 95% had complete recovery; 3 patients remained with ocular sequelae. This is the first attempt to characterize CSD-FUO as a unique syndrome that may be severe and debilitating and often mimics malignancy. Relapsing fever is a common clinical phenotype. Multiorgan involvement is common. Recovery was complete in all patients except in those with ocular disease.

Sections du résumé

BACKGROUND
Fever of unknown origin (FUO) is a rare manifestation of cat scratch disease (CSD). Data regarding CSD-associated FUO (CSD-FUO), particularly in adults, are limited. We aimed to study disease manifestations and long-term clinical outcome.
METHODS
A national CSD surveillance study has been conducted in Israel since 1991. Data are obtained using questionnaires, review of medical records, and telephone interviews. FUO was defined as fever of ≥14 days without an identifiable cause. CSD-FUO patients were identified in the 2004-2017 CSD national registry. Follow-up included outpatient clinic visits and telephone/e-mail surveys.
RESULTS
The study included 66 CSD-FUO patients. Median age was 35.5 years (range, 3-88). Median fever duration was 4 weeks (range, 2-9). Relapsing fever pattern was reported in 52% of patients, weight loss in 57%, and night sweats in 48%. Involvement of ≥1 organs occurred in 59% of patients; hepatosplenic space-occupying lesions (35%), abdominal/mediastinal lymphadenopathy (20%), ocular disease (18%), and multifocal osteomyelitis (6%) were the most common. Malignancy, particularly lymphoma, was the initial radiological interpretation in 21% of patients; 32% underwent invasive diagnostic procedures. Of the 59 patients available for follow-up (median duration, 31 weeks; range, 4-445), 95% had complete recovery; 3 patients remained with ocular sequelae.
CONCLUSION
This is the first attempt to characterize CSD-FUO as a unique syndrome that may be severe and debilitating and often mimics malignancy. Relapsing fever is a common clinical phenotype. Multiorgan involvement is common. Recovery was complete in all patients except in those with ocular disease.

Identifiants

pubmed: 31758684
pii: 5638304
doi: 10.1093/cid/ciz1137
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2818-2824

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Michal Landes (M)

Infectious Disease Unit, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Yasmin Maor (Y)

Infectious Disease Unit, Wolfson Medical Center, Holon, Israel, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Diego Mercer (D)

Department of Radiology, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Zohar Habot-Wilner (Z)

Division of Ophthalmology, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Efraim Bilavsky (E)

Schneider Children's Medical Center, Petah Tiqva, Israel, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Bibiana Chazan (B)

Infectious Diseases Unit, Emek Medical Center, Afula, Israel, and Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Regev Cohen (R)

Infectious Diseases Unit, Sanz Medical Center, Laniado Hospital, Netanya, Israel, and Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Daniel Glikman (D)

Azrieli Faculty of Medicine in the Galilee, Bar-Ilan University, Safed, Israel.

Jacob Strahilevitz (J)

Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University, Jerusalem, Israel.

Michal Katzir (M)

Infectious Disease Unit, Meir Medical Center, Kfar Saba, Israel.

Vladislav Litachevsky (V)

Infectious Disease Unit, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.

Rimma Melamed (R)

Pediatric Infectious Disease Unit, Soroka University Medical Center, Beer-Sheva, Israel.

Alex Guri (A)

Department of Pediatrics, Kaplan Medical Center, Rehovot, Israel, and School of Medicine, Hebrew University and Hadassah Medical Center, Jerusalem, Israel.

Hila Shaked (H)

Infectious Diseases Unit, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Odelya Perets (O)

Infectious Disease Unit, Soroka University Medical Center, Beer Sheva, Israel.

Yonit Wiener-Well (Y)

Infectious Disease Unit, Shaare Zedek Medical Center, Hebrew University, Jerusalem, Israel.

Anat Stren (A)

Infectious Diseases Institute, Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Michal Paul (M)

Infectious Diseases Institute, Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Oren Zimhony (O)

Infectious Diseases Unit, Kaplan Medical Center, Rehovot, Israel, and School of Medicine, Hebrew University and Hadassah, Jerusalem, Israel.

Isaac Srugo (I)

Department of Pediatrics, Bnai Zion Medical Center, Haifa, Israel, and Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Galia Rahav (G)

Infectious Disease Unit, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Jihad Bishara (J)

Infectious Diseases Unit, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Amir A Kuperman (AA)

Blood Coagulation Service and Pediatric Hematology Clinic, Galilee Medical Center, Nahariya, Israel, and Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.

Ronen Ben-Ami (R)

Infectious Disease Unit, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Moshe Ephros (M)

Pediatric Infectious Disease Unit, Carmel Medical Center and Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Michael Giladi (M)

Infectious Disease Unit, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH